Variations in plasma soluble tumour necrosis factor receptors after diet-induced weight loss in obesity

Area of Science:

• Endocrinology
• Obesity Research
• Metabolic Syndrome

Background:

• Soluble tumor necrosis factor receptors (sTNFR-I and sTNFR-II) are biomarkers associated with inflammation and metabolic dysfunction.
• Obesity is linked to chronic low-grade inflammation, potentially involving the tumor necrosis factor (TNF) pathway.
• The role of adipose tissue as a source of sTNFRs in human obesity requires further elucidation.

Purpose of the Study:

• To investigate the changes in plasma levels of soluble tumor necrosis factor receptor type-I (sTNFR-I) and type-II (sTNFR-II) during a very low-calorie diet-induced weight loss intervention.
• To explore the relationship between weight loss, specifically reduction in body fat mass, and plasma sTNFR levels in non-diabetic obese women.

Main Methods:

• A 3-week very low-calorie diet (3.9+/-0.1 MJ/day) was administered to 17 non-diabetic obese women.
• Plasma concentrations of sTNFR-I and sTNFR-II were measured before and after the dietary intervention.
• Changes in body fat mass were assessed in conjunction with plasma sTNFR level variations.

Main Results:

• A significant decrease in plasma sTNFR-I concentrations was observed following the 3-week weight loss period (p < 0.05).
• No significant changes were detected in plasma sTNFR-II levels.
• The intervention resulted in a significant reduction of body fat mass (approximately 2.5 kg).

Conclusions:

• Weight loss induced by a very low-calorie diet significantly reduces plasma sTNFR-I levels in obese women.
• These findings support the hypothesis that adipose tissue is a significant source of sTNFR-I production in humans.
• Modulation of sTNFR-I production by weight loss suggests a potential therapeutic target for obesity-related inflammatory processes.